R. Di Mauro
Papers
2
Total Citations
261
H-Index
2
About
R. Di Mauro is a leading figure in the field of radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) and the treatment of oligometastatic and recurrent cancers. His most impactful work centers on the application of CyberKnife robotic image-guided stereotactic radiotherapy, demonstrating its precision and efficacy in managing isolated recurrent prostate cancer, as well as lymph node and metastatic disease. His seminal 2011 paper on this topic has garnered over 230 citations, underscoring its influence in establishing SBRT as a viable, non-invasive option for patients with limited metastatic burden. Di Mauro’s contributions have been instrumental in advancing the paradigm of oligometastatic cancer management, offering targeted, high-dose radiation with minimal toxicity. His research continues to shape clinical protocols, providing a critical evidence base for the use of robotic radiosurgery in challenging oncologic scenarios. Through his work, Di Mauro has helped bridge the gap between technological innovation and patient-centered care, making him a respected authority in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2